Get Live Data

focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE
Stephen Yiu, FM at WS Blue Whale, discusses Nvidia, Visa/Mastercard, Lam Research & Allied Materials
Stephen Yiu, FM at WS Blue Whale, discusses Nvidia, Visa/Mastercard, Lam Research & Allied MaterialsView Video
Ben Turney, CEO at Kavango Resources, explains the company's progress from exploration to mining
Ben Turney, CEO at Kavango Resources, explains the company's progress from exploration to miningView Video

Latest Share Chat

  2. Share Prices
  3. Futura Medical Share Price
  4. Futura Medical Share News
  5. UK Earnings, Trading Statements Calendar - Next 7 Days

Pin to quick picksFutura Medical Share News (FUM)

Futura Medical Information

Share Price Information for Futura Medical (FUM)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 39.00
Bid: 38.50
Ask: 38.75
Change: -0.575 (-1.47%)
Spread: 0.25 (0.649%)
Open: 39.05
High: 39.20
Low: 39.00
Prev. Close: 39.20
FUM Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UK Earnings, Trading Statements Calendar - Next 7 Days

Wed, 05th Sep 2018 16:13

Thursday 6 September 
PPHE Hotel GroupHalf Year Results
Hunters PropertyHalf Year Results
International PPLHalf Year Results 
Mpac GroupHalf Year Results 
Deepmatter GroupHalf Year Results 
Melrose IndustriesHalf Year Results 
Dixons CarphoneQ1 Results
McCarthy & StoneTrading Statement 
Bovis HomesHalf Year Results 
GenusFull Year Results
ReddeFull Year Results
Go-Ahead GroupFull Year Results
McBrideFull Year Results
Just GroupHalf Year Results 
BakkavorHalf Year Results 
International Public PartnershipsHalf Year Results 
easyJetAugust Traffic Statistics
Friday 7 September 
Secure Income REITHalf Year Results 
Ashmore GroupFull Year Results 
EnquestHalf Year Results 
Greene KingTrading Statement 
Pacific Horizon Investment Trust Full Year Results 
Monday 10 September 
AbcamFull Year Results
Associated British FoodsTrading Statement 
HGCapital TrustHalf Year Results
Gulf Keystone PetroleumHalf Year Results 
BradyHalf Year Results 
Tuesday 11 September 
Ashtead GroupQ1 Results
JD Sports FashionHalf Year Results
Sanne GroupHalf Year Results
Midwich GroupHalf Year Results
Alumasc GroupFull Year Results
Vectura GroupHalf Year Results
Cairn EnergyHalf Year Results
Hilton FoodHalf Year Results
HarworthHalf Year Results
EU SupplyHalf Year Results
DP EurasiaHalf Year Results
Puretech HealthHalf Year Results
Surgical InnovationsHalf Year Results
Silence TherapeuticsHalf Year Results
Wednesday 12 September 
Galliford TryFull Year Results 
Property FranchiseHalf Year Results
iGasHalf Year Results
1pmHalf Year Results
Epwin GroupHalf Year Results
Ten EntertainmentHalf Year Results
Futura MedicalHalf Year Results
Dunelm GroupFull Year Results 
WilmingtonFull Year Results 
Medica GroupHalf Year Results
Safestore HoldingsQ3 Results
Charles TaylorHalf Year Results
Advanced Medical Solutions GroupHalf Year Results
  

More News
2 Mar 2010 12:38

Small caps round-up: Share, Jetion Solar, Futura Medical...

Share, parent company of retail stockbroker The Share Centre, lifted profits last year to £2.35m from £1.46m on turnover of £14.1m, up from £12m. There was a significant increase in retail investor activity - especially online with deal volumes up by 75% on 2008, Share said. The interim dividend is

Read more
16 Dec 2009 08:43

Futura a step closer to TPR100 deal

Consumer healthcare product developer Futura Medical is in talks with a major pharmaceutical company on a licensing deal for its pain relief product, TPR100. The company interested in licensing TPR100 is the same one with which Futura announced an evaluation agreement in July 2009. Futura has rece

Read more
12 Nov 2009 14:32

Small caps round-up: Syntopix, Atlantic Coal, Brady...

Drug developer Syntopix shares rallied as it reported positive phase 2 results for its lead dermatological compound SYN0126, for the treatment of acneic skin. Following the results, Syntopix has decided to focus its development efforts around three specific core compounds: SYN0126, SYN1113 and SYN

Read more
10 Nov 2009 09:22

Production changes in line for Futura condom

Futura Medical said a number of potential improvements to the production process of its ‘erectogenic’ condom have been identified by Durex condom maker SSL International. The proposed changes to the manufacturing process at SSL’s manufacturing facility in India have the potential to improve product

Read more
23 Sep 2009 13:10

Small caps round-up: Lifeline Scientific, Autologic, Bond...

The market liked Lifeline Scientific's maiden interim operating profit of $73,000 versus last year's loss of $3.1m, as the sale of 11 new LifePort kidney transporters helped revenue jump 123% to $7.75m. 'Trading was in-line with management's expectations during the first half and the board is confi

Read more
20 Jul 2009 08:35

Small caps round-up: Abbeycrest, Synchronica, Futura...

Jewellery maker Abbeycrest said it is performing in line with expectations as it undergoes a turnaround plan. The unbranded jewellery business is delivering much improved results on a significantly reduced turnover, the firm said. The brands division is making good progress with its higher margin b

Read more
10 Jun 2009 08:27

Small caps round-up: Intelligent Environments, LPA Group, Mobile Streams...

Banking software firm Intelligent Environments said trading in the current year to date has been robust. The group said it has experienced strong demand from new and existing customers to launch platforms to attract and retain retail deposits online. "Our strategy to develop a long term recurring r

Read more
13 May 2009 09:20

Small caps round-up: H&T Group, China Medical, Fyffes...

Pawnbroker H&T Group said it has traded "significantly" ahead of expectations for the year to date. It also said it was positive about prospects for the current year but remains conscious of the current difficult economic climate. "The principal reason for the strong performance is the sustained go

Read more
6789101112131415

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.